Navigation Links
FDA Approves New Drug to Treat Type I and Type II Diabetes

still need better blood sugar control; will follow their doctor's instructions exactly; will follow-up with their doctor often; will test their blood sugar levels before and after every meal, and at bedtime; and understand how to adjust Symlin and insulin doses.

Symlin should not be used if patients cannot tell when their blood sugar is low, have gastroparesis (slow stomach emptying), or are allergic to pramlintide acetate, metacresol, D-mannitol, acetic acid, or sodium acetate.

Side effects associated with Symlin include but are not limited to nausea, vomiting, abdominal pain, headache, fatigue and dizziness.

Symlin has not been evaluated in the pediatric population.

Symlin is manufactured by Amylin Pharmaceuticals, Inc. of San Diego, California.


'"/>

Source:US FDA


Page: 1 2

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. FDA Approves New Treatment for Chronic Hepatitis B
3. Discovery Could Lead To Novel Approaches In HIV Treatment
4. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss
7. Effective Cancer Treatments Follow The Clock
8. FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain
9. Potential Drug Target For Treating Cocaine Abuse Found
10. Protein Discovery Could Unlock The Secret To Better TB Treatment
11. Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers

Post Your Comments:
(Date:11/8/2009)... Ind. - Researchers at Purdue University have disc...fibers in spinal cord injuries using nano-spheres ...r an accident. , The synthetic "copolymer micell...in diameter, or roughly 100 times smaller than the...e been studying how to deliver drugs for cancer tr...
(Date:11/6/2009)...ration is now open for the Society of Intervention...gy (IO) Therapies" Webinar, which will provide the...treatment of liver tumors, kidney tumor ablation a...tion of physicians, scientists and allied health p...through pioneering advances in image-guided therap...
(Date:11/6/2009)...6 Auburn Hills, MI-based Law Enfor...talling its locker system and patent-pending Biome...Department of Health and Human Services, National ... The locker system will support the NIH,s entire p... nation,s medical research agency. The project is...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2EPA grant to University of Chicago for research on food allergy triggers 9332 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 1Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 3
...hiny amber jewelry and a mucky Florida swamp have ...m that could be anywhere from 15 million to 130 mi...f Florida and the Museum of Natural History in Ber...quatic critters such as beetles and small crustace...the water from pine-like trees. Their findings are...
...ber 17, 2007. -- It all started as a graduate scho...ire to figure out why things live where they do, s...ive in different places? Ive been studying the dis...ears. So I even made this question the basis of my...s. , That burning desire led Neilson to develop t...
... the leading cause of death due to infectious dise...lion people are currently infected, and although m... occur. This paper by Denise Kirschner and colleag...ducts virtual clinical trials to examine the cause... (TNF) is a protein that facilitates cellcell comm...
Other Biology News:Scientists find how amber becomes death trap for watery creatures 2Scientists find how amber becomes death trap for watery creatures 3Neilson member of Nobel Prize-winning panel of scientists 2
(Date:11/6/2009)...RNewswire-FirstCall/ -- ,, 3Q09 Corporate Hi...M) E.U. Marketing Authorization to Astellas Pharma...cial readiness activities Expanded management tea... and Director, Commercial Operations Appointed Br...ommittee chairman , Upcoming 2009 Milestone...
(Date:11/6/2009)...FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NAS...nounced updated results from a Phase II study of i...etastatic to the lung in a poster presentation at ... Meeting held in Miami Beach, Florida, from Novemb...A Phase II Study of Intravenous REOLYSIN (Wild-typ...
(Date:11/6/2009)...da for Arrowhead’s 2010 Personalized Medicin...ace on February 22-24, 2010 in Philadelphia, has b...l highlight key issues in forming partnerships and...es. , Minneapolis, MN (PR...rsquo;s 2010 Personalized Medicine Partnerships C...
(Date:11/5/2009)...RNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNV...third quarter ended September 30, 2009. GenVec rep... for the three months ended September 30, 2009 com...re) in the comparable quarter of 2008. For the nin...ss was $14.1 million ($0.15 per share), compared t...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Biosciences announces,an enhanced matching funds ...n in genomics. $1.75 million in matching funds is ... to each qualifying institution. The,Genomics Educ... streamlined,application process to help colleges ...ndergraduate students studying molecular biology a...
...n combats an,alarming rise in chronic diseases, th...rica (PhRMA) today released a new report on the ne...hat offer hope to millions,of patients., The repo...d,biotechnology companies - including several loca...tech medicines., Today,s report was released in M...
...ble Oils has reached a,key milestone in its effort...tunities for Montana farmers. The company received... a department of the Federal Drug,Administration, ...ot beef,cattle and growing swine up to 2 percent o... a by-product of camelina oil extraction., Sustai...
Other Biology Technology:New Report on 633 Biotechnology Medicines Under Development Released in Michigan 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 3Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 2Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 3
CORNING CELLSTACK FILLINGD CAP, 33MM, BARBED FITTING, STERILE from Sigma-Aldrich
CORNING CELLSTACK FILLINGD CAP, 33MM, LUER LOCK FITTING, STERILE from Sigma-Aldrich
RNA Sample Loading Buffer from Sigma-Aldrich
...EM and harvested at the log phase of growth. In o...ells were fixed in acetone-methanol. The cells ar...e, with each wells surface specifically treated to...round staining. Each well is loaded with approxim...
Biology Products: